Revel Pharmaceuticals Inc.
Biotechnology company · San Francisco, California, United States
Revel Pharmaceuticals Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2019. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $2.9 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $5.8 million sold in a notice filed in 2022.
Revel Pharmaceuticals at a glance
What does Revel Pharmaceuticals do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $2.9 million in total (2023 to 2025). NIH funding came from the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $5.8 million sold (2022).
Frequently asked questions about Revel Pharmaceuticals
Where is Revel Pharmaceuticals headquartered?
Revel Pharmaceuticals Inc. is headquartered in San Francisco, California, United States.
What does Revel Pharmaceuticals do?
Revel Pharmaceuticals Inc. is a biotechnology company.
When was Revel Pharmaceuticals founded?
The earliest incorporation on record for Revel Pharmaceuticals Inc. is in 2019, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences